Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAAs and HCC Recurrence After Ablation
NCT04653818Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir, velpatasvir in hepatitis C (HCV), sponsored by Alexandria University. Started Oct 2020; status: completed.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04653818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04653818.